{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:56:02Z","timestamp":1784141762953,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Older adults with chronic obstructive pulmonary disease (COPD) are at substantially increased risk for medication-related adverse events. Two frequently prescribed classes of drugs that pose a particular risk to this patient group are opioids and benzodiazepines. Research on this topic has yielded conflicting findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The purpose of this study was to examine, among older adults with COPD, whether: 1) independent or concurrent use of opioid and benzodiazepine medications was associated with hospitalizations for respiratory events, and 2) this association was exacerbated by the presence of obstructive sleep apnea (OSA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a case\u2013control study of Medicare beneficiaries aged \u226566 years, who were diagnosed with COPD in 2013, using the 5% national Medicare database. Cases (n\u2009=\u20093,232) were defined as patients hospitalized for a primary COPD-related respiratory diagnosis in 2014 and were matched with up to two control subjects (n\u2009=\u20096,247) on index date, age, sex, socioeconomic status, comorbidity, presence of OSA, COPD medication, and COPD complexity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In comparison to the referent (no opioid or benzodiazepine use), opioid use alone (adjusted odds ratio [aOR], 1.73; 95% confidence interval [CI], 1.52\u20131.97), benzodiazepine use alone (aOR, 1.42; 95% CI, 1.21\u20131.66), and concurrent opioid\/ benzodiazepine use (aOR, 2.32; 95% CI, 1.94\u20132.77) in the 30 days before the event\/index date were all associated with an increased risk of hospitalization for a respiratory condition. Risk of hospitalization was higher with concurrent opioid and benzodiazepine use when compared with use of either medication alone. There was no statistically significant interaction between OSA and either of the drugs, alone or in combination. However, the adverse respiratory effects of concurrent opioid and benzodiazepine use were increased in patients with a high degree of COPD complexity. All of the above findings persisted using exposure windows that extended to 60 and 90 days before the event\/index date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among older adults with COPD, use of opioid and benzodiazepine medications alone or in combination were associated with increased adverse respiratory events. The adverse effects of these medications were not exacerbated in patients with COPD\u2013OSA overlap syndrome. However, the adverse impact of dual opioid and benzodiazepine was greater in patients with high-complexity COPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201901-024oc","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T15:05:54Z","timestamp":1558191954000},"page":"1245-1251","source":"Crossref","is-referenced-by-count":44,"title":["Association of Opioid and Benzodiazepine Use with Adverse Respiratory Events in Older Adults with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"16","author":[{"given":"Jacques","family":"Baillargeon","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and Community Health"},{"name":"Sealy Center on Aging, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency Program, San Joaquin General Hospital, French Camp, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Community Health"},{"name":"Sealy Center on Aging, and"},{"name":"Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaila A.","family":"Raji","sequence":"additional","affiliation":[{"name":"Sealy Center on Aging, and"},{"name":"Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Westra","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Community Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Sharma","sequence":"additional","affiliation":[{"name":"Sealy Center on Aging, and"},{"name":"Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"2026012203400535500_bib1","article-title":"2018 Global strategy for prevention, diagnosis and management of COPD.","author":"Global Initiative for Chronic Obstructive Lung Disease","year":"2018"},{"key":"2026012203400535500_bib2","first-page":"1","article-title":"Chronic obstructive pulmonary disease surveillance--United States, 1971-2000","volume":"51","author":"Mannino","year":"2002","journal-title":"MMWR Surveill Summ"},{"key":"2026012203400535500_bib3","first-page":"567","article-title":"Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population","volume":"2","author":"Anecchino","year":"2007","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203400535500_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000281880","article-title":"Prevalence of comorbidities in patients with chronic obstructive pulmonary disease","volume":"80","author":"Cazzola","year":"2010","journal-title":"Respiration"},{"key":"2026012203400535500_bib5","doi-asserted-by":"crossref","first-page":"e018404","DOI":"10.1136\/bmjopen-2017-018404","article-title":"Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study","volume":"8","author":"Hanlon","year":"2018","journal-title":"BMJ Open"},{"key":"2026012203400535500_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bcp.12762","article-title":"Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study","volume":"81","author":"Vozoris","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2026012203400535500_bib7","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.2147\/COPD.S112484","article-title":"Prescription of opioids for breathlessness in end-stage COPD: a national population-based study","volume":"11","author":"Ahmadi","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203400535500_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1183\/13993003.01967-2015","article-title":"Incident opioid drug use and adverse respiratory outcomes among older adults with COPD","volume":"48","author":"Vozoris","year":"2016","journal-title":"Eur Respir J"},{"key":"2026012203400535500_bib9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00228-017-2278-3","article-title":"Adverse cardiac events associated with incident opioid drug use among older adults with COPD","volume":"73","author":"Vozoris","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2026012203400535500_bib10","doi-asserted-by":"crossref","first-page":"g445","DOI":"10.1136\/bmj.g445","article-title":"Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study","volume":"348","author":"Ekstr\u00f6m","year":"2014","journal-title":"BMJ"},{"key":"2026012203400535500_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40266-013-0056-1","article-title":"Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study","volume":"30","author":"Vozoris","year":"2013","journal-title":"Drugs Aging"},{"key":"2026012203400535500_bib12","first-page":"69","article-title":"Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline","volume":"18","author":"Marciniuk","year":"2011","journal-title":"Can Respir J"},{"key":"2026012203400535500_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/jpm.2010.0068","article-title":"Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer","volume":"13","author":"Bausewein","year":"2010","journal-title":"J Palliat Med"},{"key":"2026012203400535500_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"key":"2026012203400535500_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","article-title":"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society","volume":"155","author":"Qaseem","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026012203400535500_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/jpm.2012.0505","article-title":"The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam","volume":"16","author":"Allcroft","year":"2013","journal-title":"J Palliat Med"},{"issue":"1","key":"2026012203400535500_bib17","first-page":"CD007354","article-title":"Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults","author":"Simon","year":"2010","journal-title":"Cochrane Database Sys Rev"},{"key":"2026012203400535500_bib18","doi-asserted-by":"crossref","first-page":"e1110","DOI":"10.1097\/MD.0000000000001110","article-title":"Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study","volume":"94","author":"Chung","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026012203400535500_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1378\/chest.12-1911","article-title":"Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis","volume":"144","author":"Atlantis","year":"2013","journal-title":"Chest"},{"key":"2026012203400535500_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"key":"2026012203400535500_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1183\/09031936.00008014","article-title":"Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD","volume":"44","author":"Vozoris","year":"2014","journal-title":"Eur Resp J"},{"key":"2026012203400535500_bib22","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1532-5415.2011.03586.x","article-title":"Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study","volume":"59","author":"Dublin","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"2026012203400535500_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1513\/AnnalsATS.201802-145OC","article-title":"Risks of benzodiazepines in chronic obstructive pulmonary disease with comorbid posttraumatic stress disorder","volume":"16","author":"Donovan","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203400535500_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1513\/AnnalsATS.201501-034OC","article-title":"Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: a systematic review","volume":"12","author":"Ekstr\u00f6m","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203400535500_bib25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1513\/AnnalsATS.201506-379LE","article-title":"High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease","volume":"12","author":"Soler","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203400535500_bib26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.201210-1922ED","article-title":"Obesity hypoventilation syndrome: an underdiagnosed and undertreated condition","volume":"186","author":"P\u00e9pin","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203400535500_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/AnnalsATS.201712-932OC","article-title":"Obstructive sleep apnea with chronic obstructive pulmonary disease among Medicare beneficiaries","volume":"16","author":"Starr","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203400535500_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2174\/1573398X11666150915213406","article-title":"Overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea: a two-faced janus","volume":"11","author":"Corlateanu","year":"2015","journal-title":"Curr Respir Med Rev"},{"key":"2026012203400535500_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.200912-1869OC","article-title":"Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome","volume":"182","author":"Marin","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203400535500_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11325-018-1680-0","article-title":"Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA","volume":"23","author":"Singh","year":"2019","journal-title":"Sleep Breath"},{"key":"2026012203400535500_bib31","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1378\/chest.128.3.1339","article-title":"Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients","volume":"128","author":"Teichtahl","year":"2005","journal-title":"Chest"},{"key":"2026012203400535500_bib32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.chest.2016.05.022","article-title":"Opioids and sleep-disordered breathing","volume":"150","author":"Van Ryswyk","year":"2016","journal-title":"Chest"},{"key":"2026012203400535500_bib33","first-page":"1358","article-title":"The pathogenesis of obstructive sleep apnea","volume":"7","author":"Pham","year":"2015","journal-title":"J Thorac Dis"},{"key":"2026012203400535500_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4637.2007.00343.x","article-title":"Sleep-disordered breathing and chronic opioid therapy","volume":"9","author":"Webster","year":"2008","journal-title":"Pain Med"},{"key":"2026012203400535500_bib35","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/0002-9343(90)90282-I","article-title":"Benzodiazepines, breathing, and sleep","volume":"88","author":"Guilleminault","year":"1990","journal-title":"Am J Med"},{"key":"2026012203400535500_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/thoraxjnl-2018-211675","article-title":"The effect of acute morphine on obstructive sleep apnoea: a randomised double-blind placebo-controlled crossover trial","volume":"74","author":"Rowsell","year":"2019","journal-title":"Thorax"},{"key":"2026012203400535500_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.resp.2012.11.014","article-title":"The effects of a single mild dose of morphine on chemoreflexes and breathing in obstructive sleep apnea","volume":"185","author":"Wang","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"2026012203400535500_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2869.2011.00931.x","article-title":"Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness","volume":"20","author":"Wang","year":"2011","journal-title":"J Sleep Res"},{"key":"2026012203400535500_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"2026012203400535500_bib40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.5664\/jcsm.2916","article-title":"Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome","volume":"9","author":"Stanchina","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"2026012203400535500_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6963-11-43","article-title":"Identifying and characterizing COPD patients in US managed care: a retrospective, cross-sectional analysis of administrative claims data","volume":"11","author":"Mapel","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"2026012203400535500_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1378\/chest.06-2846","article-title":"Spirometry utilization for COPD: how do we measure up?","volume":"132","author":"Han","year":"2007","journal-title":"Chest"},{"key":"2026012203400535500_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1164\/rccm.201003-0406OC","article-title":"Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure","volume":"183","author":"Javaheri","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203400535500_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12882-016-0229-3","article-title":"Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using Medicare data","volume":"17","author":"Tuohy","year":"2016","journal-title":"BMC Nephrol"},{"key":"2026012203400535500_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1378\/chest.11-0024","article-title":"The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations","volume":"141","author":"Stein","year":"2012","journal-title":"Chest"},{"key":"2026012203400535500_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HCR.0000000000000194","article-title":"Pulmonary rehabilitation utilization in older adults with chronic obstructive pulmonary disease, 2003 to 2012","volume":"36","author":"Nishi","year":"2016","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026012203400535500_bib47","first-page":"27","article-title":"Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy","volume":"9","author":"Corhay","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203400535500_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/10\/1245\/66382369\/annalsats_16_10_1245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/10\/1245\/66382369\/annalsats_16_10_1245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:44:24Z","timestamp":1769071464000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/16\/10\/1245\/8423524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201901-024oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,10,1]]}}}